Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Astellas Makes Leadership Changes

This article was originally published in Scrip

Executive Summary

Astellas Pharma Inc. has appointed Martin Golden senior vice president and head of marketing strategy, and Frank Hudson has been promoted to senior vice president and head of budget and control, medical and development at the company. Having previously held leadership roles at Novartis AG, Johnson & Johnson and Bristol-Myers Squibb, Golden has been vice president government affairs for Astellas US since 2014. Hudson previously held financial leadership roles at Agensys, MannKind Corporation and GlaxoSmithKline plc. In addition, the company has announced three promotions: Walt Johnston, Mark Reisenauer and Kenton Stewart have been promoted to senior vice presidents, with responsibility for commercial activities in the US in urology and hospital, oncology and hospital and health systems, respectively.Johnston has been with Astellas since 2008 and most recently was vice president of US marketing and strategic new product planning and prior to this, he was at Pfizer Inc. Before Astellas, Reisenauer held various roles at Abbott, Pharmacia, Bristol-Myers Squibb and AstraZeneca PLC. Stewart has held a range of leadership roles at Astellas and most recently was responsible for US health systems.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

SC064736

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

All set! This Question has been sent to my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel